Trial Profile
A Phase 1 clinical study of DRGT-46 and DRGT-47 for the treatment of acute and chronic pain
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Aug 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 23 Dec 2016 New trial record
- 19 Dec 2016 Results published in the Druggability Technologies Media Release.